Abstract

The purpose of the study is to analyze the changes in the pharmaceutical industry in Russia in 2020. Recently, Russia has been facing an acute threat to the economic security of the pharmaceutical industry, due to the likelihood of increasing influence on the Russian industry by world players. Therefore, the analysis of the possibilities of innovative import substitution of foreign supplies to increase the level of security of the country in the field of drug supply has now become particularly relevant. The scientific novelty lies in the justification of the availability of opportunities for the development of innovative import substitution of medicines in Russia. As a result, the latest trends confirm the prospects for further effective development of the domestic pharmaceutical industry.